TSC1 promotes B cell maturation but is dispensable for germinal center formation
The main differences between the two peptides are the following: Development and Approval: Semaglutide was developed later (2010) than liraglutide, and it also received FDA approval much more recently for type 2 diabetes treatment (2017), cardiovascular risk reduction in diabetes (2021) and overweight and obesity management in adults (2021) and adolescents (2023)
Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G,
Breaching the blood-brain barrier as a gate to psychiatric disorder
An elevated level of the liver enzyme GGT is another gauge of heavy alcohol use and liver injury
The CONFIDENCE is currently examining the effect of empagliflozin and finerenone combination therapy on kidney outcomes in CKD patients with diabetes [58]